Cyclo Therapeutics, Inc. - Warrant Aktie - Unternehmensdaten & Kurse - US23254X1101 | goSPATZ

Cyclo Therapeutics, Inc. - Warrant

Share · US23254X1101 · CYTHW (XNAS)

Overview Financial Indicators

No Price

n/a

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	0,00 %	-82,67 %	-75,00 %	-84,76 %	-96,80 %

Company Profile for Cyclo Therapeutics, Inc. - Warrant Share

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Company Data

Name Cyclo Therapeutics, Inc. - Warrant

Company Cyclo Therapeutics, Inc.

Symbol CYTHW

Website http://www.cyclotherapeutics.com

Primary Exchange

NASDAQ

ISIN US23254X1101

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. N. Scott Fine

Country United States of America

Currency USD

Employees 0,0 T

IPO Date 2020-12-18

Ticker Symbols

Name	Symbol
NASDAQ	CYTHW

More Shares

Investors who Cyclo Therapeutics, Inc. - Warrant hold also have the following shares in their portfolio:

EVERTEC INC Share

SHERW.FING 24/29 REGS Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025